These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. [Interleukin-2 and cancer immunotherapy]. Ogarkov VI; Dobkin AI; Ryzhova EV; Okulov VB; Kiselev OI Vopr Onkol; 1989; 35(2):141-50. PubMed ID: 2648678 [No Abstract] [Full Text] [Related]
14. Immunotherapy of metastases. Schirrmacher V; Umansky V; Rocha M Curr Top Microbiol Immunol; 1996; 213 ( Pt 3)():189-216. PubMed ID: 8815005 [No Abstract] [Full Text] [Related]
15. Potentiation of the in vitro cytotoxicity of chlorambucil by monoclonal antibodies. Smyth MJ; Pietersz GA; McKenzie IF J Immunol; 1986 Nov; 137(10):3361-6. PubMed ID: 3772105 [TBL] [Abstract][Full Text] [Related]
16. Tumor immunotherapy. Manson LA Immunol Today; 1989 Feb; 10(2):36. PubMed ID: 2787650 [No Abstract] [Full Text] [Related]
17. An introduction to tumour immunology. James K Arch Immunol Ther Exp (Warsz); 1983; 31(6):795-808. PubMed ID: 6611141 [TBL] [Abstract][Full Text] [Related]
18. Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes. Masui H; Moroyama T; Mendelsohn J Cancer Res; 1986 Nov; 46(11):5592-8. PubMed ID: 3756906 [TBL] [Abstract][Full Text] [Related]
19. Prospects for immunotoxin therapy in cancer. Frankel AE; Houston LL; Issell BF; Fathman G Annu Rev Med; 1986; 37():125-42. PubMed ID: 3518602 [TBL] [Abstract][Full Text] [Related]
20. Immunoliposomes for cancer treatment. Park JW; Hong K; Kirpotin DB; Papahadjopoulos D; Benz CC Adv Pharmacol; 1997; 40():399-435. PubMed ID: 9217932 [No Abstract] [Full Text] [Related] [Next] [New Search]